KommentarEditorialOpen Access
Interleukin 2 for patients with renal cancer
Nature Clinical Practice Oncology · 2007-09 · 4 (9) · 497-497
DOI: 10.1038/ncponc0926 ↗Kurz gefasst
Kommentar in der Zeitschrift Nature Clinical Practice Oncology, 2007-09. Verfasst von Steven A Rosenberg. Die Arbeit wurde bisher 58-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Dose-Response Relationship, DrugFollow-Up StudiesHumansInterleukin-2Kidney NeoplasmsNeoplasm MetastasisNeoplasm Recurrence, LocalTime FactorsTreatment Outcome
Substanzen
Interleukin-2
Förderung
- Intramural NIH HHS
Zitieren
APA
Rosenberg, S. A. (2007). Interleukin 2 for patients with renal cancer. Nature Clinical Practice Oncology, 4(9), 497-497. https://doi.org/10.1038/ncponc0926
Vancouver
Rosenberg SA. Interleukin 2 for patients with renal cancer. Nature Clinical Practice Oncology. 2007;4(9):497-497. doi:10.1038/ncponc0926
BibTeX
@article{Rosenberg2007,
author = {Rosenberg, Steven A},
title = {Interleukin 2 for patients with renal cancer},
journal = {Nature Clinical Practice Oncology},
year = {2007},
volume = {4},
number = {9},
pages = {497--497},
doi = {10.1038/ncponc0926}
}
EUVIMED